3/28
04:01 pm
mrvi
MRVI Equity Alert: Kessler Topaz Meltzer & Check, LLP Alerts Shareholders of Securities Fraud Class Action Lawsuit Filed against Maravai LifeSciences Holdings, Inc. (MRVI)
Medium
Report
MRVI Equity Alert: Kessler Topaz Meltzer & Check, LLP Alerts Shareholders of Securities Fraud Class Action Lawsuit Filed against Maravai LifeSciences Holdings, Inc. (MRVI)
3/28
01:45 pm
mrvi
Maravai LifeSciences Holdings, Inc. (MRVI) Admits to Incorrect Revenue Recognition, Ineffective Internal Controls; Class Action Pending – Hagens Berman
Low
Report
Maravai LifeSciences Holdings, Inc. (MRVI) Admits to Incorrect Revenue Recognition, Ineffective Internal Controls; Class Action Pending – Hagens Berman
3/28
10:17 am
mrvi
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences
Low
Report
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences
3/28
05:45 am
mrvi
MRVI LAWSUIT ALERT: Levi & Korsinsky Notifies Maravai LifeSciences Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
Low
Report
MRVI LAWSUIT ALERT: Levi & Korsinsky Notifies Maravai LifeSciences Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
3/27
01:03 pm
mrvi
Contact Levi & Korsinsky by May 5, 2025 Deadline to Join Class Action Against Maravai LifeSciences Holdings, Inc. (MRVI)
Neutral
Report
Contact Levi & Korsinsky by May 5, 2025 Deadline to Join Class Action Against Maravai LifeSciences Holdings, Inc. (MRVI)
3/27
12:48 pm
mrvi
ROSEN, A RANKED AND LEADING FIRM, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRVI
Neutral
Report
ROSEN, A RANKED AND LEADING FIRM, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRVI
3/27
12:00 pm
mrvi
Maravai LifeSciences Holdings, Inc. (MRVI) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Low
Report
Maravai LifeSciences Holdings, Inc. (MRVI) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
3/27
12:00 pm
mrvi
Maravai LifeSciences Holdings, Inc. (MRVI) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Low
Report
Maravai LifeSciences Holdings, Inc. (MRVI) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
3/27
05:45 am
mrvi
Class Action Filed Against Maravai LifeSciences Holdings, Inc. (MRVI) Seeking Recovery for Investors - Contact The Gross Law Firm
Medium
Report
Class Action Filed Against Maravai LifeSciences Holdings, Inc. (MRVI) Seeking Recovery for Investors - Contact The Gross Law Firm
3/26
04:21 pm
mrvi
Faruqi & Faruqi Reminds Maravai Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025 - MRVI
Low
Report
Faruqi & Faruqi Reminds Maravai Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025 - MRVI
3/26
04:00 pm
mrvi
MRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Low
Report
MRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
3/26
02:52 pm
mrvi
MRVI Announcement: Kessler Topaz Meltzer & Check, LLP Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Investors to Contact the Firm About Securities Fraud Class Action Lawsuit
Low
Report
MRVI Announcement: Kessler Topaz Meltzer & Check, LLP Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Investors to Contact the Firm About Securities Fraud Class Action Lawsuit
3/26
02:24 pm
mrvi
Maravai LifeSciences Holdings, Inc. (MRVI) Faces Securities Class Action After Delaying Q4 and FY 2024 Earnings Release, Admitting to Improper Revenue Recognition – Hagens Berman
Low
Report
Maravai LifeSciences Holdings, Inc. (MRVI) Faces Securities Class Action After Delaying Q4 and FY 2024 Earnings Release, Admitting to Improper Revenue Recognition – Hagens Berman
3/26
01:06 pm
mrvi
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) was given a new $5.00 price target on by analysts at Stifel Nicolaus.
Low
Report
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) was given a new $5.00 price target on by analysts at Stifel Nicolaus.
3/26
11:18 am
mrvi
Shareholders that lost money on Maravai LifeSciences Holdings, Inc. (MRVI) should contact The Gross Law Firm about pending Class Action - MRVI
Low
Report
Shareholders that lost money on Maravai LifeSciences Holdings, Inc. (MRVI) should contact The Gross Law Firm about pending Class Action - MRVI
3/26
09:46 am
mrvi
MRVI Investors Reminded of Opportunity to Lead Maravai LifeSciences Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Low
Report
MRVI Investors Reminded of Opportunity to Lead Maravai LifeSciences Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
3/26
08:00 am
mrvi
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRVI
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRVI
3/25
05:52 pm
mrvi
Levi & Korsinsky Reminds Maravai LifeSciences Holdings, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025 - MRVI
Low
Report
Levi & Korsinsky Reminds Maravai LifeSciences Holdings, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025 - MRVI
3/25
05:13 pm
mrvi
MRVI Investors Have Opportunity to Lead Maravai Lifesciences Holdings, Inc. Securities Fraud Lawsuit
Low
Report
MRVI Investors Have Opportunity to Lead Maravai Lifesciences Holdings, Inc. Securities Fraud Lawsuit
3/25
10:47 am
mrvi
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) had its price target lowered by analysts at Morgan Stanley from $7.00 to $5.00. They now have an "equal weight" rating on the stock.
Low
Report
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) had its price target lowered by analysts at Morgan Stanley from $7.00 to $5.00. They now have an "equal weight" rating on the stock.
3/25
10:21 am
mrvi
Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc.
Low
Report
Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc.
3/25
10:00 am
mrvi
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holidngs, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRVI
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holidngs, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRVI
3/24
04:14 pm
mrvi
ROSEN, A TOP RANKED LAW FIRM, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRVI
Low
Report
ROSEN, A TOP RANKED LAW FIRM, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRVI
3/24
04:00 pm
mrvi
Maravai LifeSciences Holdings, Inc. (MRVI) Faces Securities Class Action After Delaying Q4 and FY 2024 Earnings Release, Admitting to Improper Revenue Recognition – Hagens Berman
Low
Report
Maravai LifeSciences Holdings, Inc. (MRVI) Faces Securities Class Action After Delaying Q4 and FY 2024 Earnings Release, Admitting to Improper Revenue Recognition – Hagens Berman
3/24
02:33 pm
mrvi
Maravai LifeSciences Holdings, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights – MRVI
Low
Report
Maravai LifeSciences Holdings, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights – MRVI